Are Interleukins Changing the Way we Treat Depression?
نویسندگان
چکیده
منابع مشابه
Changing the Way We Assess Leadership
Defense leaders face unprecedented challenges of accelerating change in a world without a Cold War. The technology explosion is forcing reduced cycle times as acquisition leaders lead the way to “better, faster, and cheaper.” Specific initiatives and reforms such as single process initiative, electrical combat/electronic data interchange (EC/EDI), cost as an independent variable, and increased ...
متن کاملEarly psoriatic arthritis: should we treat it in the same way as we treat rheumatoid arthritis?
2015 Joint damage predicts functional limitation and mortality in psoriatic arthritis patients, but evidence from cohort studies supports the idea that early diagnosis and treatment are beneficial. Given the revolution in the treatment of rheumatoid arthritis, treating to targets and close control have become attractive concepts in the clinical management of psoriatic arthritis. The evidence in...
متن کاملWhat is the best way to treat bipolar depression?
John, a 38-year-old man who has had one previous episode of depression after the break-up of a relationship, presents with moderately depressed mood of 3 months’ duration. This time, there is no clear reason for the episode. John has no suicidal ideation. However, on further questioning he states that over the past 8 years he has also noticed periods of mild to moderate mood elevation lasting 1...
متن کاملHow the Web Is Changing the Way We Trust
Several studies have addressed the issue of what makes information on the World Wide Web credible. Understanding how we select reliable sources of information and how we estimate their credibility has been drawing an increasing interest in the literature on the Web. In this paper I argue that the study of information search behavior can provide to social and cognitive scientists an extraordinar...
متن کاملThe World is Changing – Are We Ready?
It is clear that there is an ongoing revolution in medicine as cost and regulatory pressures begin to intersect with our clinical responsibilities for the care of patients. In the past, particularly in the area of in vitro diagnostics, all that was required for approval for clinical use of biomarkers was an analytically robust measuring system, a reasonable analytic validation, a modicum of cli...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Physical Fitness, Medicine & Treatment in Sports
سال: 2018
ISSN: 2577-2945
DOI: 10.19080/jpfmts.2018.04.555645